Medicinal Cannabis for Children: Evidence and Recommendations
About this webinar
In recent years, there has been growing interest and debate surrounding the use of cannabis-derived products in paediatric medicine. Parents, caregivers, healthcare professionals, and policymakers are seeking evidence-based guidance on the safety, efficacy, and appropriate use of medical cannabis for children. This webinar offers a comprehensive overview of the current evidence and recommendations concerning medical cannabis use in paediatric populations. Our expert speaker will draw upon the latest research and clinical insights to delve into safety considerations, risk mitigation strategies, and the exploration of potential therapeutic benefits across various paediatric conditions, including epilepsy, autism spectrum disorder, cancer-related symptoms, and beyond.
Understand the evidence-based safety, efficacy, and application of medical cannabis in paediatric medicine.
Learn practical safety measures and risk mitigation strategies for paediatric medical cannabis use.
Identify potential therapeutic benefits for paediatric conditions like epilepsy, autism spectrum disorder, and cancer-related symptoms.
Dr. Lauren Kelly is an associate professor in pharmacology and therapeutics at the University of Manitoba. She is a scientist at the Children’s Hospital Research Institute of Manitoba, certified clinical research professional and a clinical trialist at the George and Fay Yee Centre for Healthcare Innovation. She received a PhD in pharmacology and toxicology from the University of Western Ontario and completed two Post-doctoral Fellowships at the Hospital for Sick Children and at Mount Sinai Hospital in Toronto. Dr. Kelly is the scientific director of the Canadian Collaborative for Childhood Cannabinoid Therapeutics, a pan-Canadian research platform that studies the safety of cannabis products used for medical purposes in the pediatric population. Her program involves partnering with parents, doctors, nurses, pharmacists and policy makers to design and conduct a variety of clinical research studies.
When: Tuesday, 9 April 2024
Time: 7:00 pm